EcoDrugPlus

Amine Oxidase Copper Containing 1

Ensembl ID : ENSOMYG00000035385
Gene Symbol: AOC1
1 Cross references
225 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSOMYG00000010827
Gene Symbol: APP
1 Cross references
196 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSOMYG00000035519
Gene Symbol: APP
1 Cross references
197 Possible Orthologues:

Androgen Receptor Alpha

Ensembl ID : ENSOMYG00000045899
Gene Symbol: AR-ALPHA
2 Cross references
206 Possible Orthologues:

Androgen Receptor Beta

Ensembl ID : ENSOMYG00000013733
Gene Symbol: AR-BETA
3 Cross references
207 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSOMYG00000016833
Gene Symbol: AGTR1
1 Cross references
193 Possible Orthologues:

Apelin Receptor 2

Ensembl ID : ENSOMYG00000070050
Gene Symbol: APLNR2
1 Cross references
171 Possible Orthologues:

Arachidonate 12-Lipoxygenase

Ensembl ID : ENSOMYG00000041596
Gene Symbol: ALOX12
2 Cross references
191 Possible Orthologues:

Arachidonate 5-Lipoxygenase A

Ensembl ID : ENSOMYG00000020325
Gene Symbol: ALOX5A
1 Cross references
220 Possible Orthologues:

Arachidonate 5-Lipoxygenase A

Ensembl ID : ENSOMYG00000043777
Gene Symbol: ALOX5A
1 Cross references
2 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSOMYG00000007858
Gene Symbol: ALOX5AP
1 Cross references
194 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSOMYG00000028186
Gene Symbol: ALOX5AP
1 Cross references
194 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).